Results 71 to 80 of about 56,482 (307)
Insurance impacts survival for children, adolescents, and young adults with bone and soft tissue sarcomas. [PDF]
, 2020 BackgroundWhile racial/ethnic survival disparities have been described in pediatric oncology, the impact of income has not been extensively explored. We analyzed how public insurance influences 5-year overall survival (OS) in young patients with sarcomas.
Goldsby, Robert E +5 more
core +1 more source
Multi-modality management of chondrosarcoma of scapula: A case report and review of literature
Cancer Treatment and Research Communications, 2023 Chondrosarcoma are malignant tumours in which neoplastic cells produce cartilage. The most commonly affected sites are pelvis, femur, humerus and ribs. Scapula involvement is relatively rare.
Ramakant Tiwari +5 more
doaj +1 more source
A system-level approach identifies HIF-2α as a critical regulator of chondrosarcoma progression
Nature Communications, 2020 Chondrosarcomas, malignant cartilaginous neoplasms, are capable of transitioning to highly aggressive, metastatic, and treatment-refractory states, resulting in significant patient mortality.
Hyeon-Seop Kim +11 more
semanticscholar +1 more source
The in ovo CAM-assay as a xenograft model for sarcoma [PDF]
, 2013 Sarcoma is a very rare disease that is heterogeneous in nature, all hampering the development of new therapies. Sarcoma patients are ideal candidates for personalized medicine after stratification, explaining the current interest in developing a ...
Bracke, Marc +6 more
core +1 more source
Dedifferentiated chondrsarcoma: a clinicopathologic analysis of 25 cases
BMC Musculoskeletal Disorders, 2021 Background To investigate the clinical, imaging and pathological features of dedifferentiated chondrosarcoma for better diagnosis. Methods Patients who had been confirmed to have dedifferentiated chondrosarcoma were enrolled in this study and analyzed in
Lei Cao +7 more
doaj +1 more source
Mutant IDH1 Depletion Downregulates Integrins and Impairs Chondrosarcoma Growth
Cancers, 2020 Chondrosarcomas are a heterogeneous group of malignant bone tumors that produce hyaline cartilaginous matrix. Mutations in isocitrate dehydrogenase enzymes (IDH1/2) were recently described in several cancers, including conventional and dedifferentiated ...
Luyuan Li +12 more
semanticscholar +1 more source
Advanced Image‐Guidance and Surgical‐Navigation Techniques for Real‐Time Visualized Surgery
Advanced Science, EarlyView.This review comprehensively summarizes advances in surgical navigation, covering both established and emerging intraoperative imaging technologies. It highlights mechanisms, advantages, limitations, and clinical applications, while emphasizing interdisciplinary collaboration.
Xiaoxiao Fan +9 more
wiley +1 more source
Clinical Cancer Research, 2019 Purpose: Chondrosarcomas are the second most common primary malignant bone tumors. Although histologic grade is the most important factor predicting the clinical outcome of chondrosarcoma, it is subject to interobserver variability.
G. Zhu +15 more
semanticscholar +1 more source
Extraskeletal myxoid chondrosarcoma of the masticator space in a pediatric patient [PDF]
, 2017 Extraskeletal myxoid chondrosarcoma (EMC) is a malignant soft-tissue neoplasm rarely described in the head and neck region of children and adolescents. We describe a case of EMC affecting the masticator space and a literature review.
Almeida, Oslei Paes de +4 more
core +1 more source
Sinonasal Sarcomas Management: An International Consensus Statement
International Forum of Allergy &Rhinology, EarlyView.ABSTRACT Introduction Sinonasal sarcomas are exceedingly rare entities, constituting less than 7% of head and neck sarcomas. Their complex histology needs specialized treatment, which is often based on multimodal approaches including surgery, radiation therapy, and/or chemotherapy.
Alessandro Vinciguerra +51 more
wiley +1 more source